Literature DB >> 3726333

Assessment of laboratory methods for detection of unsuspected diabetes in primary health care.

P O Bitzén, B Scherstén.   

Abstract

In order to assess different methods for early detection of unsuspected diabetes, urine and venous blood samples were collected at random from 1082 patients visiting a primary health care centre in southern Sweden. Blood glucose was analysed by the hexokinase method along with the Dextrostix-Eyetone reflectance meter. Urine glucose was determined by Clinistix, Diastix, Neostix, Rediatest, Clinitest and quantitatively by the hexokinase method. Patients fulfilling the criteria of a positive screen were subjected to a diagnostic investigation with an oral glucose tolerance test. Out of 89 positive screenees, 37 patients were classified as diabetics, showing a prevalence of diabetes in the study population of 3.4% according to the WHO criteria. Impaired glucose tolerance was found in 14 patients. In a control group of 56 patients, randomly selected among negative screenees, no cases of diabetes were found. Random blood glucose measurement by the hexokinase method, using 7 mmol/l as a screening level, had a significantly higher sensitivity (95%) than all urine glucose methods (59-30%) with comparable specificity (97-99%). Use of the Dextrostix-Eyetone reflectance meter resulted in a decrease in sensitivity to 75% without any change in specificity or predictability, compared with the hexokinase method. Urine testing for glucose was found to be a suboptimal method for early case finding of diabetes among patients receiving primary health care.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3726333     DOI: 10.3109/02813438609014809

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  7 in total

1.  Quality of life among diabetic patients in Swedish primary health care and in the general population: comparison between 1992 and 1995.

Authors:  P E Wändell; B Brorsson; H Aberg
Journal:  Qual Life Res       Date:  1998-12       Impact factor: 4.147

Review 2.  Periodic health examination, 1992 update: 1. Screening for gestational diabetes mellitus. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1992-08-15       Impact factor: 8.262

3.  The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia.

Authors:  P O Bitzén; A Melander; B Scherstén; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Long-term effects of glipizide on insulin secretion and blood glucose control in patients with non-insulin-dependent diabetes mellitus.

Authors:  P O Bitzén; A Melander; B Scherstén; M Svensson; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 5.  Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

Authors:  A Melander; P O Bitzén; O Faber; L Groop
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

6.  Assessing the prevalence of the Metabolic Syndrome according to NCEP ATP III in Germany: feasibility and quality aspects of a two step approach in 1550 randomly selected primary health care practices.

Authors:  Susanne Moebus; Jens Ulrich Hanisch; Markus Neuhäuser; Pamela Aidelsburger; Jürgen Wasem; Karl-Heinz Jöckel
Journal:  Ger Med Sci       Date:  2006-10-09

7.  The value of screening for diabetes in patients with skin sepsis.

Authors:  C Baynes; S Caplan; P Hames; R Swift; S Poole; J Wadsworth; R Touquet; R S Elkeles
Journal:  J R Soc Med       Date:  1993-03       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.